Meprobamate: still approved in France: labelling change. No role for meprobamate, in any indication. Safer options are available
Prescrire International 17(95): 108
2008
ISSN/ISBN: 1167-7422 PMID: 18623919 Document Number: 615272
Document emailed within 1 workday
Related Documents
Michotte, Y.; Massart, D.L.; Dryon, L. 1977: The determination of meprobamate with the NH3 probe Pharmaceutica Acta Helvetiae 52(6-7): 152-153Kergueris, M.F.; Thomas, A.; Bourin, M. 1994: Research of meprobamate in emergency toxicology: identification in urine Annales de Biologie Clinique 52(6): 469-470
Laroche, B.; Hoang The Dan, P.; Lapandry, C.; de Preville, G.; Pourriat, J.L. 1984: Acute meprobamate poisoning. Efficacy of peritoneal dialysis Cahiers d'Anesthesiologie 32(8): 677-679
Draguet-Brughmans, M.; Azibi, M.; Bouché, R. 1979: Solubility and dissolution rate of meprobamate: significant cases Journal de Pharmacie de Belgique 34(5): 267-271
Bismuth, C.; Baud, F.J.; Galliot, M.; du Fretay, X.H.; de Kerviller, E. 1985: Liver metabolism of meprobamate: clinical estimation in acute intoxication Journal de Toxicologie Clinique et Experimentale 5(5): 321-328
Migdal, A. 1969: A case of crisis in chronic adrenal failure provoked by meprobamate Wiadomosci Lekarskie 22(9): 849-852
Trémolières, F.; Vachon, F.; Amoudry, C.; Bourdon, R.; Gibert, C. 1977: The value of dialysis by hemoperfusion on an activated charcoal column in severe meprobamate poisoning La Nouvelle Presse Medicale 6(35): 3225-3226
Moriya, F.; Ishizu, H. 1992: Effect of long-term ethanol administration on meprobamate level in brain of rat Arukoru Kenkyu to Yakubutsu Izon 27(1): 103-110
Rickels, K.; Gordon, P.E.; Jenkins, B.W.; Sablosky, L.; Vlachos, V.A.; Weise, C.C.; Whalen, E.M.; Wilson, D.A. 1971: Combination of meprobamate and benactyzine (Deprol) and constituents in neurotic depressed outpatients Diseases of the Nervous System 32(7): 457-467
Mercier, J.; Dessaigne, S.; Menguy, A.; Manez, J. 1974: Electro-encephalographic study on the action of the combination meprobamate-aceprometazine on various cerebral systems Arzneimittel-Forschung 24(2): 163-166
Gebauer, D. 1971: Prevention and therapy of cardiac rhythm disorders. Experiences with a diphenylhydantoin-meprobamate preparation (Cusitan) Münchener Medizinische Wochenschrift 113(12): 436-440
Cazabat, A.; Kochman, S.; Bureau, G.; Dubois de Montreynaud, J.M. 1971: Comparison of chlorzepate, meprobamate, and diazepam effects on the pulmonary function of a group of patients with respiratory insufficiency Journal Francais d'Oto-Rhino-Laryngologie Audio-Phonologie et Chirurgie Maxillo-Faciale 20(7): 857-863
Tonda, A.; Garcia-Cordovilla, R.; Martinez-Rodriguez, R. 1991: Presence of meprobamate-like molecules in rat neuromuscular junction. Immunohistochemical demonstration at light- and electron-microscopic levels Cellular and Molecular Biology 37(2): 149-154
Sweetman, B.J.; Baig, A.; Parsons, D.L. 1987: Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobamate: a comparative study in acute low back pain British Journal of Clinical Practice 41(2): 619-624
Gaillard, Y.; Pépin, G.; Cabrera, B. 1995: Rapid, simple and sensitive identification of meprobamate in plasma or urine using Toxi-Tube-B zero from Toxi-Lab and colored reaction on filter paper Annales de Biologie Clinique 53(6): 361-362
De Tapia, S. 2009: Permanences et mutations de l'immigration turque en France : Les Turcs en France quels ancrages ? - Continuity and change of Turkish immigration in France : Which anchors for turks in France ? Hommes and Migrations (1987) (1280): 8-20
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2